Medical Devices & Consumables

Global Research Grade Antibodies Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Research Grade Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Research Grade Antibodies.
The Research Grade Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Research Grade Antibodies market comprehensively. Regional market sizes, concerning products by Source, by End User, by Host Species and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Research Grade Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Source, by End User, and by regions.
Market Segmentation
By Company
Abcam
Merck
CST
Thermo Fisher
R&D Systems
BD
Biolegend
Proteintech
ABclonal
Bio-Rad
Santa Cruz Biotechnology (SCBT)
Novus Biologicals
Genetex
Abnova
Abcepta
Aviva Biosciences
MBL
BioXCell
Sino Biological
HuaBio
Segment by Source
Monoclonal Antibodies
Polyclonal Antibodies
Segment by Host Species
Mouse Antibody
Rabbit Antibody
Goat Antibody
Sheep Antibody
Donkey Antibody
Chicken Antibody
Others
Segment by Application
For Basic Research
For Drug Discovery
For Translational/Diagnostic Research
Others
Segment by End User
Pharmaceutical & Biotechnology Companies
CRO/CDMO Companies
Academic & Research Institutes
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Source, by End User, by Host Species etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Research Grade Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Source
1.2.1 Global Research Grade Antibodies Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 Market by Host Species
1.3.1 Global Research Grade Antibodies Market Size Growth Rate by Host Species: 2020 VS 2024 VS 2031
1.3.2 Mouse Antibody
1.3.3 Rabbit Antibody
1.3.4 Goat Antibody
1.3.5 Sheep Antibody
1.3.6 Donkey Antibody
1.3.7 Chicken Antibody
1.3.8 Others
1.4 Market by Application
1.4.1 Global Research Grade Antibodies Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.4.2 For Basic Research
1.4.3 For Drug Discovery
1.4.4 For Translational/Diagnostic Research
1.4.5 Others
1.5 Market by End User
1.5.1 Global Research Grade Antibodies Market Growth by End User: 2020 VS 2024 VS 2031
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 CRO/CDMO Companies
1.5.4 Academic & Research Institutes
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Research Grade Antibodies Market Perspective (2020-2031)
2.2 Global Research Grade Antibodies Growth Trends by Region
2.2.1 Global Research Grade Antibodies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Research Grade Antibodies Historic Market Size by Region (2020-2025)
2.2.3 Research Grade Antibodies Forecasted Market Size by Region (2026-2031)
2.3 Research Grade Antibodies Market Dynamics
2.3.1 Research Grade Antibodies Industry Trends
2.3.2 Research Grade Antibodies Market Drivers
2.3.3 Research Grade Antibodies Market Challenges
2.3.4 Research Grade Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Research Grade Antibodies Players by Revenue
3.1.1 Global Top Research Grade Antibodies Players by Revenue (2020-2025)
3.1.2 Global Research Grade Antibodies Revenue Market Share by Players (2020-2025)
3.2 Global Top Research Grade Antibodies Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Research Grade Antibodies Revenue
3.4 Global Research Grade Antibodies Market Concentration Ratio
3.4.1 Global Research Grade Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Research Grade Antibodies Revenue in 2024
3.5 Global Key Players of Research Grade Antibodies Head office and Area Served
3.6 Global Key Players of Research Grade Antibodies, Product and Application
3.7 Global Key Players of Research Grade Antibodies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Research Grade Antibodies Breakdown Data by Source
4.1 Global Research Grade Antibodies Historic Market Size by Source (2020-2025)
4.2 Global Research Grade Antibodies Forecasted Market Size by Source (2026-2031)
5 Research Grade Antibodies Breakdown Data by End User
5.1 Global Research Grade Antibodies Historic Market Size by End User (2020-2025)
5.2 Global Research Grade Antibodies Forecasted Market Size by End User (2026-2031)
6 North America
6.1 North America Research Grade Antibodies Market Size (2020-2031)
6.2 North America Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Research Grade Antibodies Market Size by Country (2020-2025)
6.4 North America Research Grade Antibodies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Research Grade Antibodies Market Size (2020-2031)
7.2 Europe Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Research Grade Antibodies Market Size by Country (2020-2025)
7.4 Europe Research Grade Antibodies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Research Grade Antibodies Market Size (2020-2031)
8.2 Asia-Pacific Research Grade Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Research Grade Antibodies Market Size by Region (2020-2025)
8.4 Asia-Pacific Research Grade Antibodies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Research Grade Antibodies Market Size (2020-2031)
9.2 Latin America Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Research Grade Antibodies Market Size by Country (2020-2025)
9.4 Latin America Research Grade Antibodies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Research Grade Antibodies Market Size (2020-2031)
10.2 Middle East & Africa Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Research Grade Antibodies Market Size by Country (2020-2025)
10.4 Middle East & Africa Research Grade Antibodies Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Research Grade Antibodies Introduction
11.1.4 Abcam Revenue in Research Grade Antibodies Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Research Grade Antibodies Introduction
11.2.4 Merck Revenue in Research Grade Antibodies Business (2020-2025)
11.2.5 Merck Recent Development
11.3 CST
11.3.1 CST Company Details
11.3.2 CST Business Overview
11.3.3 CST Research Grade Antibodies Introduction
11.3.4 CST Revenue in Research Grade Antibodies Business (2020-2025)
11.3.5 CST Recent Development
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Details
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Research Grade Antibodies Introduction
11.4.4 Thermo Fisher Revenue in Research Grade Antibodies Business (2020-2025)
11.4.5 Thermo Fisher Recent Development
11.5 R&D Systems
11.5.1 R&D Systems Company Details
11.5.2 R&D Systems Business Overview
11.5.3 R&D Systems Research Grade Antibodies Introduction
11.5.4 R&D Systems Revenue in Research Grade Antibodies Business (2020-2025)
11.5.5 R&D Systems Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Research Grade Antibodies Introduction
11.6.4 BD Revenue in Research Grade Antibodies Business (2020-2025)
11.6.5 BD Recent Development
11.7 Biolegend
11.7.1 Biolegend Company Details
11.7.2 Biolegend Business Overview
11.7.3 Biolegend Research Grade Antibodies Introduction
11.7.4 Biolegend Revenue in Research Grade Antibodies Business (2020-2025)
11.7.5 Biolegend Recent Development
11.8 Proteintech
11.8.1 Proteintech Company Details
11.8.2 Proteintech Business Overview
11.8.3 Proteintech Research Grade Antibodies Introduction
11.8.4 Proteintech Revenue in Research Grade Antibodies Business (2020-2025)
11.8.5 Proteintech Recent Development
11.9 ABclonal
11.9.1 ABclonal Company Details
11.9.2 ABclonal Business Overview
11.9.3 ABclonal Research Grade Antibodies Introduction
11.9.4 ABclonal Revenue in Research Grade Antibodies Business (2020-2025)
11.9.5 ABclonal Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Details
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Research Grade Antibodies Introduction
11.10.4 Bio-Rad Revenue in Research Grade Antibodies Business (2020-2025)
11.10.5 Bio-Rad Recent Development
11.11 Santa Cruz Biotechnology (SCBT)
11.11.1 Santa Cruz Biotechnology (SCBT) Company Details
11.11.2 Santa Cruz Biotechnology (SCBT) Business Overview
11.11.3 Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Introduction
11.11.4 Santa Cruz Biotechnology (SCBT) Revenue in Research Grade Antibodies Business (2020-2025)
11.11.5 Santa Cruz Biotechnology (SCBT) Recent Development
11.12 Novus Biologicals
11.12.1 Novus Biologicals Company Details
11.12.2 Novus Biologicals Business Overview
11.12.3 Novus Biologicals Research Grade Antibodies Introduction
11.12.4 Novus Biologicals Revenue in Research Grade Antibodies Business (2020-2025)
11.12.5 Novus Biologicals Recent Development
11.13 Genetex
11.13.1 Genetex Company Details
11.13.2 Genetex Business Overview
11.13.3 Genetex Research Grade Antibodies Introduction
11.13.4 Genetex Revenue in Research Grade Antibodies Business (2020-2025)
11.13.5 Genetex Recent Development
11.14 Abnova
11.14.1 Abnova Company Details
11.14.2 Abnova Business Overview
11.14.3 Abnova Research Grade Antibodies Introduction
11.14.4 Abnova Revenue in Research Grade Antibodies Business (2020-2025)
11.14.5 Abnova Recent Development
11.15 Abcepta
11.15.1 Abcepta Company Details
11.15.2 Abcepta Business Overview
11.15.3 Abcepta Research Grade Antibodies Introduction
11.15.4 Abcepta Revenue in Research Grade Antibodies Business (2020-2025)
11.15.5 Abcepta Recent Development
11.16 Aviva Biosciences
11.16.1 Aviva Biosciences Company Details
11.16.2 Aviva Biosciences Business Overview
11.16.3 Aviva Biosciences Research Grade Antibodies Introduction
11.16.4 Aviva Biosciences Revenue in Research Grade Antibodies Business (2020-2025)
11.16.5 Aviva Biosciences Recent Development
11.17 MBL
11.17.1 MBL Company Details
11.17.2 MBL Business Overview
11.17.3 MBL Research Grade Antibodies Introduction
11.17.4 MBL Revenue in Research Grade Antibodies Business (2020-2025)
11.17.5 MBL Recent Development
11.18 BioXCell
11.18.1 BioXCell Company Details
11.18.2 BioXCell Business Overview
11.18.3 BioXCell Research Grade Antibodies Introduction
11.18.4 BioXCell Revenue in Research Grade Antibodies Business (2020-2025)
11.18.5 BioXCell Recent Development
11.19 Sino Biological
11.19.1 Sino Biological Company Details
11.19.2 Sino Biological Business Overview
11.19.3 Sino Biological Research Grade Antibodies Introduction
11.19.4 Sino Biological Revenue in Research Grade Antibodies Business (2020-2025)
11.19.5 Sino Biological Recent Development
11.20 HuaBio
11.20.1 HuaBio Company Details
11.20.2 HuaBio Business Overview
11.20.3 HuaBio Research Grade Antibodies Introduction
11.20.4 HuaBio Revenue in Research Grade Antibodies Business (2020-2025)
11.20.5 HuaBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Research Grade Antibodies Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Polyclonal Antibodies
Table 4. Global Research Grade Antibodies Market Size Growth Rate by Host Species (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Mouse Antibody
Table 6. Key Players of Rabbit Antibody
Table 7. Key Players of Goat Antibody
Table 8. Key Players of Sheep Antibody
Table 9. Key Players of Donkey Antibody
Table 10. Key Players of Chicken Antibody
Table 11. Key Players of Others
Table 12. Global Research Grade Antibodies Market Size Growth Rate by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Key Players of For Basic Research
Table 14. Key Players of For Drug Discovery
Table 15. Key Players of For Translational/Diagnostic Research
Table 16. Key Players of Others
Table 17. Global Research Grade Antibodies Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Research Grade Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Research Grade Antibodies Market Size by Region (2020-2025) & (US$ Million)
Table 20. Global Research Grade Antibodies Market Share by Region (2020-2025)
Table 21. Global Research Grade Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 22. Global Research Grade Antibodies Market Share by Region (2026-2031)
Table 23. Research Grade Antibodies Market Trends
Table 24. Research Grade Antibodies Market Drivers
Table 25. Research Grade Antibodies Market Challenges
Table 26. Research Grade Antibodies Market Restraints
Table 27. Global Research Grade Antibodies Revenue by Players (2020-2025) & (US$ Million)
Table 28. Global Research Grade Antibodies Market Share by Players (2020-2025)
Table 29. Global Top Research Grade Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Research Grade Antibodies as of 2024)
Table 30. Ranking of Global Top Research Grade Antibodies Companies by Revenue (US$ Million) in 2024
Table 31. Global 5 Largest Players Market Share by Research Grade Antibodies Revenue (CR5 and HHI) & (2020-2025)
Table 32. Global Key Players of Research Grade Antibodies, Headquarters and Area Served
Table 33. Global Key Players of Research Grade Antibodies, Product and Application
Table 34. Global Key Players of Research Grade Antibodies, Date of Enter into This Industry
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Research Grade Antibodies Market Size by Source (2020-2025) & (US$ Million)
Table 37. Global Research Grade Antibodies Revenue Market Share by Source (2020-2025)
Table 38. Global Research Grade Antibodies Forecasted Market Size by Source (2026-2031) & (US$ Million)
Table 39. Global Research Grade Antibodies Revenue Market Share by Source (2026-2031)
Table 40. Global Research Grade Antibodies Market Size by End User (2020-2025) & (US$ Million)
Table 41. Global Research Grade Antibodies Revenue Market Share by End User (2020-2025)
Table 42. Global Research Grade Antibodies Forecasted Market Size by End User (2026-2031) & (US$ Million)
Table 43. Global Research Grade Antibodies Revenue Market Share by End User (2026-2031)
Table 44. North America Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. North America Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 46. North America Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 47. Europe Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Europe Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 49. Europe Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 50. Asia-Pacific Research Grade Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 51. Asia-Pacific Research Grade Antibodies Market Size by Region (2020-2025) & (US$ Million)
Table 52. Asia-Pacific Research Grade Antibodies Market Size by Region (2026-2031) & (US$ Million)
Table 53. Latin America Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Latin America Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 55. Latin America Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 56. Middle East & Africa Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 57. Middle East & Africa Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
Table 58. Middle East & Africa Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
Table 59. Abcam Company Details
Table 60. Abcam Business Overview
Table 61. Abcam Research Grade Antibodies Product
Table 62. Abcam Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 63. Abcam Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Research Grade Antibodies Product
Table 67. Merck Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 68. Merck Recent Development
Table 69. CST Company Details
Table 70. CST Business Overview
Table 71. CST Research Grade Antibodies Product
Table 72. CST Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 73. CST Recent Development
Table 74. Thermo Fisher Company Details
Table 75. Thermo Fisher Business Overview
Table 76. Thermo Fisher Research Grade Antibodies Product
Table 77. Thermo Fisher Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 78. Thermo Fisher Recent Development
Table 79. R&D Systems Company Details
Table 80. R&D Systems Business Overview
Table 81. R&D Systems Research Grade Antibodies Product
Table 82. R&D Systems Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 83. R&D Systems Recent Development
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD Research Grade Antibodies Product
Table 87. BD Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 88. BD Recent Development
Table 89. Biolegend Company Details
Table 90. Biolegend Business Overview
Table 91. Biolegend Research Grade Antibodies Product
Table 92. Biolegend Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 93. Biolegend Recent Development
Table 94. Proteintech Company Details
Table 95. Proteintech Business Overview
Table 96. Proteintech Research Grade Antibodies Product
Table 97. Proteintech Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 98. Proteintech Recent Development
Table 99. ABclonal Company Details
Table 100. ABclonal Business Overview
Table 101. ABclonal Research Grade Antibodies Product
Table 102. ABclonal Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 103. ABclonal Recent Development
Table 104. Bio-Rad Company Details
Table 105. Bio-Rad Business Overview
Table 106. Bio-Rad Research Grade Antibodies Product
Table 107. Bio-Rad Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 108. Bio-Rad Recent Development
Table 109. Santa Cruz Biotechnology (SCBT) Company Details
Table 110. Santa Cruz Biotechnology (SCBT) Business Overview
Table 111. Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Product
Table 112. Santa Cruz Biotechnology (SCBT) Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 113. Santa Cruz Biotechnology (SCBT) Recent Development
Table 114. Novus Biologicals Company Details
Table 115. Novus Biologicals Business Overview
Table 116. Novus Biologicals Research Grade Antibodies Product
Table 117. Novus Biologicals Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 118. Novus Biologicals Recent Development
Table 119. Genetex Company Details
Table 120. Genetex Business Overview
Table 121. Genetex Research Grade Antibodies Product
Table 122. Genetex Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 123. Genetex Recent Development
Table 124. Abnova Company Details
Table 125. Abnova Business Overview
Table 126. Abnova Research Grade Antibodies Product
Table 127. Abnova Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 128. Abnova Recent Development
Table 129. Abcepta Company Details
Table 130. Abcepta Business Overview
Table 131. Abcepta Research Grade Antibodies Product
Table 132. Abcepta Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 133. Abcepta Recent Development
Table 134. Aviva Biosciences Company Details
Table 135. Aviva Biosciences Business Overview
Table 136. Aviva Biosciences Research Grade Antibodies Product
Table 137. Aviva Biosciences Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 138. Aviva Biosciences Recent Development
Table 139. MBL Company Details
Table 140. MBL Business Overview
Table 141. MBL Research Grade Antibodies Product
Table 142. MBL Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 143. MBL Recent Development
Table 144. BioXCell Company Details
Table 145. BioXCell Business Overview
Table 146. BioXCell Research Grade Antibodies Product
Table 147. BioXCell Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 148. BioXCell Recent Development
Table 149. Sino Biological Company Details
Table 150. Sino Biological Business Overview
Table 151. Sino Biological Research Grade Antibodies Product
Table 152. Sino Biological Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 153. Sino Biological Recent Development
Table 154. HuaBio Company Details
Table 155. HuaBio Business Overview
Table 156. HuaBio Research Grade Antibodies Product
Table 157. HuaBio Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
Table 158. HuaBio Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
Table 162. Authors List of This Report


List of Figures
Figure 1. Research Grade Antibodies Picture
Figure 2. Global Research Grade Antibodies Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 3. Global Research Grade Antibodies Market Share by Source: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Polyclonal Antibodies Features
Figure 6. Global Research Grade Antibodies Market Size Comparison by Host Species (2020-2031) & (US$ Million)
Figure 7. Mouse Antibody Features
Figure 8. Rabbit Antibody Features
Figure 9. Goat Antibody Features
Figure 10. Sheep Antibody Features
Figure 11. Donkey Antibody Features
Figure 12. Chicken Antibody Features
Figure 13. Others Features
Figure 14. Global Research Grade Antibodies Market Size Comparison by Application (2020-2031) & (US$ Million)
Figure 15. For Basic Research Features
Figure 16. For Drug Discovery Features
Figure 17. For Translational/Diagnostic Research Features
Figure 18. Others Features
Figure 19. Global Research Grade Antibodies Market Size by End User (2020-2031) & (US$ Million)
Figure 20. Global Research Grade Antibodies Market Share by End User: 2024 VS 2031
Figure 21. Pharmaceutical & Biotechnology Companies Case Studies
Figure 22. CRO/CDMO Companies Case Studies
Figure 23. Academic & Research Institutes Case Studies
Figure 24. Others Case Studies
Figure 25. Research Grade Antibodies Report Years Considered
Figure 26. Global Research Grade Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 27. Global Research Grade Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 28. Global Research Grade Antibodies Market Share by Region: 2024 VS 2031
Figure 29. Global Research Grade Antibodies Market Share by Players in 2024
Figure 30. Global Research Grade Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 31. The Top 10 and 5 Players Market Share by Research Grade Antibodies Revenue in 2024
Figure 32. North America Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. North America Research Grade Antibodies Market Share by Country (2020-2031)
Figure 34. United States Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Canada Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Europe Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Europe Research Grade Antibodies Market Share by Country (2020-2031)
Figure 38. Germany Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. France Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. U.K. Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Italy Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Russia Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Ireland Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Research Grade Antibodies Market Share by Region (2020-2031)
Figure 46. China Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Japan Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. South Korea Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. India Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Australia & New Zealand Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Latin America Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Latin America Research Grade Antibodies Market Share by Country (2020-2031)
Figure 54. Mexico Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Brazil Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Middle East & Africa Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Middle East & Africa Research Grade Antibodies Market Share by Country (2020-2031)
Figure 58. Israel Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. UAE Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 61. Abcam Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 63. CST Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 64. Thermo Fisher Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 65. R&D Systems Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 66. BD Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 67. Biolegend Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 68. Proteintech Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 69. ABclonal Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 70. Bio-Rad Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 71. Santa Cruz Biotechnology (SCBT) Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 72. Novus Biologicals Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 73. Genetex Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 74. Abnova Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 75. Abcepta Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 76. Aviva Biosciences Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 77. MBL Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 78. BioXCell Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 79. Sino Biological Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 80. HuaBio Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies